Sander Dale A.
SEC insider (Form 3/4/5 filer). CIK 0001878193. CFO and Chief Corp. Deve. Off. at Humacyte, Inc. (HUMA). 5 reported Form 4/5 transactions since Sep 2024; latest on May 18, 2026. Located in DURHAM, NC.
Companies Sander Dale A. has filed insider reports for
- Humacyte, Inc. (HUMA): Officer, CFO and Chief Corp. Deve. Off.
Sander Dale A.
CIK: 0001878193
Transaction Breakdown
Open Market Buys (P)1 (20.0%)
High conviction signal
Open Market Sales (S)1 (20.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (60.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HUMA
Humacyte, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 18, 2026HUMA
Humacyte, Inc.
SaleDirect45.9K shares at avg. $0.90$41K - Nov 16, 2025HUMA
Humacyte, Inc.
AwardDirect311.1K shares- - Apr 10, 2025HUMA
Humacyte, Inc.
PurchaseIndirect20K shares at avg. $1.53$31K - Jan 21, 2025HUMA
Humacyte, Inc.
AwardDirectStock Options (right to buy)
283.1K shares- - Dec 19, 2024HUMA
Humacyte, Inc.
AwardDirectStock Options (right to buy)
525 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 18, 2026 | HUMA Humacyte, Inc. | Sale | 45,887 | $0.90 | $41,147 | Direct |
| Nov 16, 2025 | HUMA Humacyte, Inc. | Award | 311,100 | - | - | Direct |
| Apr 10, 2025 | HUMA Humacyte, Inc. | Purchase | 20,000 | $1.53 | $30,600 | Indirect |
| Jan 21, 2025 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 283,101 | - | - | Direct |
| Dec 19, 2024 | HUMA Humacyte, Inc. | Award Stock Options (right to buy) | 525 | - | - | Direct |
1-5 of 5 transactions